Watch for the First Oral GLP-1 Agonist, Rybelsus, During Transitions of Care

November 2019

Semaglutide (Rybelsus, reh-BEL-sus) will be the first ORAL GLP-1 agonist for type 2 diabetes...it's a tablet version of injectable Ozempic.

Glucagon-like peptide-1 (GLP-1) is inactivated in the stomach.

That's why other GLP-1 agonists...dulaglutide (Trulicity), exenatide ER (Bydureon), liraglutide (Victoza), etc...are injected.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote